Ono Pharmaceutical Rolls Out Agentic AI Across Drug Discovery

Ono Pharmaceutical is deploying Phylo's Biomni Lab, an agentic AI platform, across its drug discovery teams to automate and enhance early-stage research tasks. Biomni Lab integrates Ono's expertise and data to support experiment design and computational biology, building on its proven capabilities in diverse biomedical tasks.